SEC SCHEDULE 13G

Company

PTC THERAPEUTICS, INC.

Filed

May 8, 2020

Accession Number

0000902219-20-000385

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →